mitotane and FMR1-Related Primary Ovarian Insufficiency studies

Mitotane: A derivative of the insecticide DICHLORODIPHENYLDICHLOROETHANE that specifically inhibits cells of the adrenal cortex and their production of hormones. It is used to treat adrenocortical tumors and causes CNS damage, but no bone marrow depression.

Research Excerpts

Excerpt	Relevance	Reference
" A 33-year-old woman who underwent surgery for adrenocortical carcinoma and treated with mitotane was referred for infertility."	8.12	Live birth after in-vitro maturation of oocytes in a patient with specific ovarian insufficiency caused by long-term mitotane treatment for adrenocortical carcinoma. ( Belin, F; Bry-Gauillard, H; Grynberg, M; Massin, N; Renoult-Pierre, P; Sifer, C; Vinolas, C; Young, J, 2022)
" A 33-year-old woman who underwent surgery for adrenocortical carcinoma and treated with mitotane was referred for infertility."	4.12	Live birth after in-vitro maturation of oocytes in a patient with specific ovarian insufficiency caused by long-term mitotane treatment for adrenocortical carcinoma. ( Belin, F; Bry-Gauillard, H; Grynberg, M; Massin, N; Renoult-Pierre, P; Sifer, C; Vinolas, C; Young, J, 2022)

Research

Studies (1)

Authors

Other Studies

1 other study available for mitotane and FMR1-Related Primary Ovarian Insufficiency

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors	Studies
Bry-Gauillard, H	1
Belin, F	1
Vinolas, C	1
Renoult-Pierre, P	1
Massin, N	1
Young, J	1
Sifer, C	1
Grynberg, M	1